Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDLP-110 in acute soft tissue injury
NCT01223053Phase 3Withdrawn
- Sponsor
- Harrow
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Ketofen in acute soft tissue injury, sponsored by Harrow. Status: withdrawn.
02
Drugs
Ketofen
03
Conditions
acute soft tissue injury
Beyond the preview
Go deeper on NCT01223053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223053.